FGF19 and polycystic ovary syndrome: Apart from diabetes, serum FGF19 level was also negatively associated with diabetes-related complications, such as diabetic retinopathy, diabetic nephropathies, subclinical atherosclerosis and polycystic ovary syndrome [10–13].